Estimated Reading Time: 1
Nigeria has begun clinical trials for the two covid-19 vaccines developed in the country, the News Agency of Nigeria reports.
Chairman of the Presidential task force on COVID-19, Boss Mustapha told journalists last week that the vaccines will be used after the completion of trials and obtaining relevant certification.
The vaccines were developed by Nigerian scientists, and described as a scientific breakthrough that will “boost the morale and image of the medical industry in the country.”
Mustapha asked all relevant agencies to provide the necessary support for the smooth running of the remaining protocols for the certification of the vaccines.
So far Nigeria has taken delivery of 4 million doses of the Oxford-Astrazeneca vaccines from the Covax initiative. The country plans to receive 16 million doses.
Earlier this year, the Federal government announced that it had pumped some $25 million to develop local vaccines to battle the coronavirus.
As of the time of filing this report, Nigeria has recorded 163,000 coronavirus cases, 152,000 have recovered and some 2,058 covid-19 related deaths have been registered.
- Rochas Okorocha says he only honoured EFCC Invitation and not arrested
- EFCC arrests Senator Rochas Okorocha
- #EndSARS: Nigerians react as Canada rejects asylum application of ex-SARS officer
- How Nigerian lawyer, Adaeze Ikpema was allegedly murdered by her husband
- Justice Aisha Bashir-Aliyu becomes Nassarawa’s first female chief Judge
- Police Inspector Fatally Injured While Repelling Multiple Kidnap Attacks in Abuja
- Insecurity: Nurses In Ogun State declare strike until ‘safety is guaranteed’
- NASS legislative aides protest unpaid salary arrears
- Nigeria – An increasing number of measles cases in Borno
- Mariam Ileyemi: Fresh wave of religious crisis shouldn’t add to Nigeria’s many problems